SCN5A mutations associated with overlap phenotype of long QT syndrome type 3 and Brugada syndrome.
Department of Pharmacology, Chiba University Graduate School of Medicine.
Haruaki
H
Nakaya
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D053840:Brugada Syndrome; D005190:Family; D005260:Female; D005424:Flecainide / Q000008:administration & dosage*; D006801:Humans; D008133:Long QT Syndrome; D008297:Male; D020125:Mutation, Missense; D062554:NAV1.5 Voltage-Gated Sodium Channel
D000889:Anti-Arrhythmia Agents; D062554:NAV1.5 Voltage-Gated Sodium Channel; C568320:SCN5A protein, human; D005424:Flecainide